NASDAQ · Biotechnology

TGTX (TGTX) Stock

$54.60 +0.54% NASDAQ: TGTX Healthcare

Valuation

MetricValue
Price$54.60
Market Cap$8.36B
P/E Ratio17.51
P/B Ratio12.17
P/S Ratio10.95
EPS (TTM)$2.77
52-Week High$59.06
52-Week Low$25.28
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE112.60%
ROA8.55%
ROCE18.98%
Gross Margin83.04%
Operating Margin21.35%
Net Margin65.95%
Debt/Equity1.29
Current Ratio4.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$3.0M$234.0M$329.0M$616.0M
Operating Profit$-345.0M$-218.0M$21.0M$42.0M$123.0M
Net Profit$-348.0M$-224.0M$13.0M$23.0M$447.0M
EPS$-2.63$-1.46$0.09$0.15$2.77
Op Margin-5154.3%-7839.0%8.8%12.7%20.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$380.0M$194.0M$330.0M$578.0M$1.1B
Total Liabilities$142.0M$135.0M$169.0M$355.0M$415.0M
Cash$299.0M$102.0M$93.0M$180.0M$79.0M
Borrowings$79.0M$83.0M$111.0M$254.0M$261.0M

Latest News

TGTX: Lowering target price to $60.00 Argus Research · Jul 15, 2026 TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations Insider Monkey · Jul 13, 2026 TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial Insider Monkey · Jul 9, 2026 TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News Simply Wall St. · Jul 9, 2026 2 Fast-Growing Pharmaceutical Stocks to Buy Now Motley Fool · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-296.0M$-176.0M$-31.0M$-41.0M$-25.0M
Investing Cash Flow$-1.0M$-20.0M$-51.0M$-1.0M$14.0M
Financing Cash Flow$-1.0M$0$1.0M$-9.0M$-91.0M
Net Cash Flow$-255.0M$-197.0M$-9.0M$87.0M$-101.0M
Free Cash Flow$-296.0M$-176.0M$-31.0M$-41.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.61
EV / EBITDA48.52
FCF Yield-0.19%
Quick Ratio5.12
Interest Coverage4.56
Return 1Y86.22%
Return 3Y415.58%
Return 5Y103.29%

Ownership

Insiders Held7.47%
Institutions Held70.25%
Institutions Float Held75.92%
Institutional HolderSharesReport Date
Blackrock Inc.22,252,9302026-03-31
State Street Corporation8,649,7662026-03-31
Vanguard Portfolio Management LLC8,273,9792026-03-31
Vanguard Capital Management LLC6,603,2582026-03-31
Soleus Capital Management, L.P.4,029,3192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
ALKS $46.75 -0.51% 25.87 $7.84B 0.00%
ARWR $82.69 +0.36% -7397.00 $11.65B 0.00%
CRSP $56.94 -0.06% -11.97 $5.49B 0.00%
IMVT $39.63 -2.91% -14.48 $8.18B 0.00%

About TGTX

TGTX is led by CEO Michael S. Weiss, employs 399 people, headquartered in Morrisville, US, publicly traded since 2010.

TGTX stock trades at $54.60 with a market capitalization of $8.36B. The stock is valued at a price-to-earnings (P/E) ratio of 17.51, price-to-book of 12.17, price-to-sales of 10.95. Over the past 52 weeks the stock has ranged between $25.28 and $59.06, and currently trades 7.6% below its 52-week high.

On profitability, TGTX generates a return on equity (ROE) of 112.60% — well above the market average, a sign of a high-quality business, return on capital employed of 18.98%, an operating margin of 21.35%, a net profit margin of 65.95%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1163.29 +0.57% JNJ Drug Manufacturers - General $270.06 +1.58% ABBV Drug Manufacturers - General $261.00 +1.79% MRK Drug Manufacturers - General $149.18 +0.96% UNH Medical - Healthcare Plans $395.72 +1.62% NVS Drug Manufacturers - General $161.66 +6.31% AZN Drug Manufacturers - General $161.97 -0.10% AMGN Drug Manufacturers - General $437.27 +1.72% TMO Medical - Diagnostics & Research $602.27 -2.40% NVO Biotechnology $45.29 -0.09% ABT Medical - Devices $109.56 -0.72% GILD Drug Manufacturers - General $149.07 +1.86%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides